Freenome (FRNM) News
NASDAQ: FRNMHealth CareMedical SpecialitiesUSD
15.78-0.03 (-0.19%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
FRNM news summary
We found 2 recent headlines mentioning Freenome (FRNM): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, FRNM is down 0.19% at $15.78. The most recent story, "Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test", was published by Nasdaq on Oct 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Freenome headlines
- Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test(RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new clinical validation data for an updated version of its SimpleScreen colorectal cancer (CRC) blood-based screening test at the…NasdaqABT, FRNM
- Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026Freenome will present late-breaking data on an updated version of its SimpleScreen CRC blood-based screening test at ACG 2026GlobeNewswire